Literature DB >> 3620297

Chloroquine excretion following malaria prophylaxis.

L L Gustafsson, B Lindström, A Grahnén, G Alván.   

Abstract

Urinary excretion of chloroquine and its desethyl-metabolite was monitored for up to 395 days after the last dose of oral chloroquine (300 mg base) taken once weekly for 10 weeks as malaria prophylaxis. Concentrations in plasma could be followed for up to 70 days after the last dose. A three exponential decay was applied to the urinary excretion data. The half-life of the terminal phase varied from 45 to 55 days for chloroquine and from 59 to 67 days for the metabolite. Mean residence time was approximately 20 days for the parent compound and 35 days for the metabolite, indicating that the terminal phases are of less importance for the effective half-lives.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3620297      PMCID: PMC1387753          DOI: 10.1111/j.1365-2125.1987.tb03165.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  IGPHARM: interactive graphic package for pharmacokinetic analysis.

Authors:  C Gomeni; R Gomeni
Journal:  Comput Biomed Res       Date:  1978-08

2.  Determination of chloroquine and its desethyl metabolite in plasma, red blood cells and urine by liquid chromatography.

Authors:  G Alván; L Ekman; B Lindström
Journal:  J Chromatogr       Date:  1982-04-16

3.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

4.  Disposition of chloroquine in man after single intravenous and oral doses.

Authors:  L L Gustafsson; O Walker; G Alván; B Beermann; F Estevez; L Gleisner; B Lindström; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

5.  Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma.

Authors:  Y Bergqvist; B Domeij-Nyberg
Journal:  J Chromatogr       Date:  1983-01-14

6.  Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples.

Authors:  L Rombo; O Ericsson; G Alván; B Lindström; L L Gustafsson; F Sjöqvist
Journal:  Ther Drug Monit       Date:  1985       Impact factor: 3.681

  6 in total
  14 in total

Review 1.  Drug treatment and prevention of malaria.

Authors:  N J White
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.

Authors:  J Ducharme; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

Review 3.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

4.  Concentrations of chloroquine and malaria parasites in blood in Nigerian children.

Authors:  F P Mockenhaupt; J May; Y Bergqvist; O G Ademowo; P E Olumese; A G Falusi; L Grossterlinden; C G Meyer; U Bienzle
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 5.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

Review 6.  Prevention of malaria.

Authors:  J S Keystone
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics of slow-acting antirheumatic drugs.

Authors:  S E Tett
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

Review 8.  HPLC methods for choloroquine determination in biological samples and pharmaceutical products.

Authors:  Yugo Araújo Martins; Talita Mota Gonçalves; Renata F V Lopez
Journal:  Daru       Date:  2021-03-19       Impact factor: 3.117

9.  Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019: Do Blood Concentrations Matter?

Authors:  Matthew M Ippolito; Charles Flexner
Journal:  Clin Infect Dis       Date:  2020-12-31       Impact factor: 9.079

10.  Analysis of platelet-derived growth factor receptor A and oligodendrocyte transcription factor 2 markers following Hydroxychloroquine administration in animal induced multiple sclerosis model.

Authors:  Hajar Amin Safaei; Seyed Mehdi Eftekhari; Mehdi Aliomrani
Journal:  Metab Brain Dis       Date:  2021-08-03       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.